is semaglutide under patent With semaglutide's expiring, generics are set to enter from soon, setting off competition in a fast-growing segment of obesity and diabetes care. https://timesofindia.indiatimes.com/toi-plus/business-economy/why-miracle-weight-loss-drugs- are Semaglutide Patent Expiry: Cheaper Weight

Briffa, J

The authors demonstrate that GLP-1R agonist treatment induces expression of tyrosine kinase IGF1R/ErbB (EGFR) pathways, however, agonist treatment can still increase intestinal growth in the absence of intestinal epithelial IGF1 receptor as well as EGF receptor signaling (Koehler et al., 2015)

Long-Smith CM, Manning S, McClean PL, Coakley MF, OHalloran DJ, Holscher C, et al

Administration of the QV formulation increased the pancreatic GLP-1R level, indicating a possible increase in the availability of GLP-1, whereas in the liver these levels did not change

Lysyl Oxidase A copper-dependent enzyme essential for crosslinking collagen and elastin chains into load-bearing structures